One of the most popular events of the week, Rheumatology Roundup: Highlights From the 2017 ACR/ARHP Annual Meeting, will help wrap up this year’s meeting. The hour-long session will take […]
On Saturday, the ACR Board of Directors met to discuss current and future initiatives impacting its 9,500 members. Here is a summary of the meeting: Increasing Access to High-Quality Education: […]
The 2017 Year in Review on Sunday provided a quick overview of the best of basic science and clinical research papers from the past year. Basic science presenter Richard M. […]
A universal influenza vaccine? The next big pandemic? What can we expect from the current presidential administration in dealing with emerging or re-emerging infectious disease? Opening Lecture speaker Anthony S. […]
A Tuesday morning session will review the preliminary results of the 2016-2017 ACR Update on Rheumatoid Arthritis Disease Activity Measures and 2016-2017 ACR Rheumatoid Arthritis Functional Status Measures. Presenters will […]
Many members of the medical community say it is possible to have too much of a good thing. Across all specialties, clinicians and researchers alike suffer from what some call […]
Discontinuing methotrexate (MTX) for two weeks after vaccination improves the immunogenicity of a seasonal influenza vaccine in patients with rheumatoid arthritis (RA) on a stable dose of MTX without meaningfully […]
A Tuesday ACR/ARHP combined session, Phenotyping Hip & Knee OA: Toward Better Clinical Care & Patient Outcomes, will explore emerging science on osteoarthritis phenotypes and how further understanding of the […]
The ACR is about to release its first-ever guideline for the management of psoriatic arthritis (PsA). Written in conjunction with the National Psoriasis Foundation (NPF), the guideline is designed for […]
The ACR is collaborating with the European League Against Rheumatism (EULAR) to develop new classification criteria for systemic lupus erythematosus (SLE). SLE is challenging to diagnose and treat, with an […]